MICHAEL S. ALEXANDER CEO, President, and Director

Mr. Michael S. Alexander,began his career as Manager of Treasure Coast Private Equity, with a focus on technology and the development of start-up companies with patented or prototype products. He participated in equity market trading, including small cap, micro cap and options, and assisted with the acquisition and advancement of existing technologies. During his time there he was invited to become a Board Member for Greenwood Gold Mining, a small public company until December of 2010. In December, 2011, Mr. Alexander became the CEO and President of Technology River Investments, the predecessor to Treasure Coast Private Equity where Mr. Alexander was incremental in the acquisition and management of numerous portfolio investments on behalf of Technology River. Mr. Alexander is a graduate of the University of North Florida,and holds a Bachelor of Science degree in Business Administration (Finance). He has been an active volunteer with a number of local philanthropic organizations, including The United Way of Martin County in Stuart, Florida.



GARY D. ALEXANDER Director, CFO & Corporate Secretary

Gary D. Alexander, is a founder and chairman of Technology River Investments, a Florida based investment firm. He has more than 30 years of experience in the fields of accounting and investment management. His knowledge and skills include initiating public and private offerings for small companies, professional accounting services with “go-public” transactions, private placement syndications, mergers, and acquisitions. He has led and participated in projects in other fields, including the aviation industry, automotive, petroleum, internet services, telephone and VoIP industries, medical facilities, cosmetic and the entertainment, music and film industries.


Previously, Mr. Alexander was chairman of Treasure Coast Private Equity, a Florida based private equity firm that specializes in providing debt and equity resources for privately owned business seeking expansion capital. In December 2011, the Company was combined with Technology River Investments.


In January 2011, he was appointed as officer and member of the board of directors of Brick Top Productions, Inc. a Florida based film production company (BTOP) until February 2014


In November 2007, Mr. Alexander was appointed outside/independent director of FirstPlus Financial Group, Inc. (FPFX) a former member of the New York Stock Exchange, was a diversified company providing commercial loans, consumer lending, residential and commercial restoration, facility maintenance services, insurance adjusting services, construction management services and facilities and restoration franchise business. In early 2008, following a managerial restructuring, he was appointed “acting CFO” and designated corporate officer for SEC interface.


Mr. Alexander earned a Bachelor of Business Administration (Accounting) degree from Florida Atlantic University, Boca Raton, FL in 1977. He owned and operated a successful CPA practice from April 1982 through December 2006. Throughout his career, he has served as a member and chair of numerous charitable organizations to help provide needed services in his local community.



ANTHONY A. GEDEON Senior VP of New Product Development

Mr. Gedeon has worked with Radiant’s Dr. Li for the past 7 years to commercialize Radiant’s nucleotide technology for cosmetics and industrial applications. He presided over the ISO level documentation program for the nucleotide Sunblock, and he assists Dr. Li in the development to production of new cosmetic and OTC products.


June 2013 to Present - Sr. Vice President, The Radiant Creation Group, Inc. (RCGP). Radiant is marketing advanced genetic and combinational western and traditional Chinese Medicine based cosmetic and OTC products for DNA protection, anti-aging, acne, liver protection, hypertension, weight loss, and complexion rejuvenation. Mr. Gedeon has presided over the organizational, developmental, and production work for these products designed by his associate, Yin-Xiong Li, MD, Ph.D., the Chief Medical Officer of China.


January 2012 to Present - Vice President of Business Development - The Renewable Corporation (RNWB). Mr. Gedeon sold part of his technology holding company in medical products and self-sterilizing coatings to The Renewable Corporation and joined the company as the Vice President of Business development and technical head of its coating manufacturing subsidiary. The Renewable Corporation is a green and medical products public company with subsidiaries in medical facilities and asbestos tile encapsulation flooring systems, self-sterilizing and self cleaning surfaces for medical facilities and implants.


Surface Modifiction Technology, Orlando FL - CEO - Mr. Gedeon was one of the co-founders of SMT in November of 2003 with Dr. Steve Schachter, MD (Professor at the Harvard Medical School BIDMC), to exploit silicon chemistries in surface treatments for medical, bio-threat, emergency vehicle, and industrial applications. Mr. Gedeon was responsible for structuring the corporate strategy, raising capital, and populating the company and its advisory boards with quality individuals. He is co-inventor on the company’s patent on self-sterilizing coatings for medical facilities and emergency vehicles. He partnered with the Ford Motor Company in evaluating his technologies for automotive applications. Mr. Gedeon sold the company to the Renewable Corporation in January of 2012.


Mr. Gedeon spent 20 years in the Washington DC area marketing and developing a wide range of high technology products to for entities ranging from large corporations to new technology start-ups, and government departments. During his tenure in the Washington DC area, he co-owned a Congressional and Pentagon liaison company, The Columbia Bay Company, serving the guided weapons and communications industries. He specialized in obtaining congressional funding and creating strategic partnerships for major smart weapons programs. Mr. Gedeon was co-founder of a physics research company, served on a White House task force for Innovative Education, and served as a technical advisor to a senior staff member of the Senate Foreign Relations Committee on capabilities of foreign physics technologies for weaponization. Mr. Gedeon holds several patents in the electronics and chemical industries. He is a graduate of the University of Michigan in Electrical Engineering.




Dr. Li is currently a Chief Medical Officer and Director of the Institute of Public Health, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Science. He is currently involved in setting up a licensing joint venture between Pfizer and the Chinese Government for a cancer-inhibiting drug. Dr. Li is further attempting to create a joint venture between China and the US to continue funding of his research to harvest adult stem cells, multiply the cells, and use them to eliminate the need for any liver transplants worldwide and other organ re-growth. Dr. Li was formerly an Assistant Professor, Dept. of Medicine (Gastroenterology and Cardiology), Pediatrics and Cell Biology, Duke University Medical School. Dr. Li has served on NIH grant boards and also was appointed to President Obama’s Stimulus Grant Board for medical research. He is considered one of the most productive geneticists in the world.


Dr. Li had the honor of his work being featured on the March 2007 cover of Nature’s “Laboratory Investigations Journal” for discovering a prevention for alcohol related birth defects. Dr. Li has developed a non-invasive monitor that can detect Fetal Alcohol Syndrome in pregnant women. The monitor also presents the technical promise of non-invasive sugar level testing and real time monitoring of critical parameters during anesthesia. After fourteen years of research, Dr. Li found and patented a method to prevent DNA damage in the skin from UV and radiation. This work has been developed into Renewable’s DNA sun block. It is expected to be used to lessen the risk of skin cancer from sunlight and to act a protection of skin during radiation procedures. Dr. Li has residences in both the US and China.




Stephen M. Dawes is President of A.I.G. Technologies, Inc. He is a degreed Chemist and ChemicalEngineer. He worked in Procter & Gamble’s Skin Care Division for six years. While at P&G, he formulated and developed manufacturing procedures for Personal Care and OTC products, including Oil of Olay,Noxema, and Bain de Soleil. Following P&G, he held the position of Technical Director at two south-eastern cosmetic companies (Key West Aloe, Solar Cosmetic Labs (d/b/a  No-Ad Suncare)). While at these firms, he developed an extensive line of personal and sun care products. He also designed and implemented new manufacturing equipment and procedures that eventually lead to the initiation of a profitable private label business. Mr. Dawes is also a member and an officer of the Florida Chapter of the Society of Cosmetic Chemists.